About ChemAxon
ChemAxon is a company based in Budapest (Hungary) founded in 1998 was acquired by Certara in July 2024. ChemAxon offers products and services including Marvin, Design Hub, and Compound Registration. ChemAxon operates in a competitive market with competitors including Insitro, Certara, HotSpot Therapeutics, CytoReason and GRO Biosciences, among others.
Products & Services of ChemAxon
ChemAxon offers a comprehensive portfolio of products and services, including Marvin, Design Hub, and Compound Registration.
Universal editor for chemical structures in research and drug discovery.
Platform for designing and tracking compounds in drug discovery teams.
System to check uniqueness of new molecules against databases.
Apps and channels of ChemAxon
its YouTube channel Chemaxon has 2.62K subscribers and 30 videos.
Videos from ChemAxon
The most watched videos on ChemAxon's YouTube channel, Chemaxon (2.62K subscribers). Click a video to play it here.
More on Chemaxon.
Funding Insights of ChemAxon
- Total Rounds 1
All 1 funding rounds of ChemAxon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2011 | – | Grant | – | – | – |
1 investors in total: 1 institutional.
Investors in ChemAxon
ChemAxon has secured backing from 1 investor. Prominent investors backing the company include Certara.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of a platform for in silico drug discovery and consulting services | 2008 | certara.com | Princeton, United States |
Investor details for ChemAxon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ChemAxon
3 dated milestones of ChemAxon across 26 years, from founding to its latest funding, stage changes and deals.
- Founded ChemAxon is founded.
- Funding First funding round.
- Exit Acquired by Certara.
Competitors of ChemAxon
ChemAxon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, Certara, HotSpot Therapeutics, CytoReason and GRO Biosciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| certara.com | 2008 | Princeton, United States | – | 827 | Provider of a platform for in silico drug discovery and consulting services | |
| hotspotthera.com | 2017 | Boston, United States | $210M | 37 | Developer of a platform for protein function analysis | |
| cytoreason.com | 2016 | Haifa, Israel | $100M | – | Immune system-based drugs are discovered via biological data analytics. | |
| grobio.com | 2016 | Boston, United States | $91.15M | 22 | Synthetic biology tools are developed via genetic code recoding techniques. | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery | |
| tolremo.com | 2017 | Zurich, Switzerland | $55.81M | – | Anti-cancer small molecules are developed to target drug resistance pathways. | |
| recludixpharma.com | 2020 | San Diego, United States | $60M | 33 | Provider of the online platform for drug discovery and development | |
| postera.ai | 2019 | London, United Kingdom | $26.2M | 3 | AI based molecular designing software for drug discovery | |
| cartography.bio | 2020 | Foster, United States | $124M | 10 | Provider of a platform to discover immunotherapeutics |
Detailed competitors of ChemAxon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ChemAxon
The website of ChemAxon (chemaxon.com) receives about 102.7K visits a month.
- Monthly visits102.7K
▼ 10.3% vs previous month
Websites whose visitors overlap most with ChemAxon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| acdlabs.com | 100% | 177.1K | #258,053 | View details | |
| eyesopen.com | 82% | 25.2K | #1,006,842 | View details | |
daylight.com | daylight.com | 82% | – | #1,065,024 | – |
| moldiscovery.com | 82% | – | – | View details | |
| chemcomp.com | 80% | 23.1K | #1,100,676 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for ChemAxon
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Chemaxon
Complete news archive for ChemAxon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ChemAxon
10 companies that operate in the same segment as ChemAxon (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ChemAxon
ChemAxon was founded in 1998 and raised its 1st funding round 13 years after it was founded.
ChemAxon is headquartered in Budapest, Hungary.
Founded in 1998 and based in Budapest, Hungary, ChemAxon develops cheminformatics software platforms, applications, and services targeted at biotechnology and pharmaceutical industries. Operations focus on chemical structure handling, visualization, data management, and analysis tools, including suites for molecular design, database integration, compliance checking, and workflow enhancements. Services support virtual library screening, text mining, and Markush structure processing across various IT environments.
ChemAxon's top competitors include Insitro, HotSpot Therapeutics and Certara.
ChemAxon offers Marvin, Design Hub, and Compound Registration.
ChemAxon has 1 investor. Key investors include Certara.
ChemAxon operates through Chemaxon Ltd..
Yes. ChemAxon was acquired by Certara in July 2024.
The website of ChemAxon receives about 103 thousand visits a month.